Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Galectin Therapeutics Inc

+ Add to Watchlist

GALT:US

3.4500 USD 0.0900 2.68%

As of 20:10:00 ET on 01/29/2015.

Company Profile for Galectin Therapeutics Inc (GALT)

Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates.

Contact Information

Galectin Therapeutics Inc

4960 Peachtree Industrial Blvd
Norcross, GA 30071
United States
Phone: 1-678-620-3186
Fax: 1-770-864-1327

Key Executives for Galectin Therapeutics Inc (GALT)

James C CzirrChairman/Co-FounderPeter G TraberPresident/CEO/Chief Medical Ofcr
Jack W CallicuttChief Financial OfficerHarold H ShlevinChief Operating Officer
Eliezer ZomerExec VP:ManufacturingSheila JayarajVP:Corp Strat & Investor Rltns
Rex HortonExecutive Director:Regulatory

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil